Article
[Cost benefit of screening for type 1 diabetes. A futuristic scenario].
Diabete & metabolisme - 1 Dec 1993
Lévy-Marchal C
Abstract excerpt
The current knowledge on prediction of Type 1 diabetes derives from family studies, as for example the BOX Study in England. Data indicate that first degree relatives with islet cells antibodies > or = 20 JDFu have a 35% risk to develop the disease within 5 years. But sensitivity and specificity of this risk marker are not high enough to allow for population screening. The tools for Type 1 diabetes screening in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
